The Antiangiogenic Effects of a Vascular Endothelial Growth Factor Decoy Receptor Can Be Monitored in Vivo Using Contrast-Enhanced Ultrasound Imaging
The development of antiangiogenic therapies has stimulated interest in noninvasive imaging methods to monitor response. We investigated whether the effects of a vascular endothelial growth factor decoy receptor (VEGF Trap, Regeneron Pharmaceuticals, Tarrytown, NY) could be monitored in vivo using co...
Saved in:
Main Authors: | Flemming Forsberg, Raymond J. Ro, Andrew Marshall, Ji-Bin Liu, See-Ying Chiou, Daniel A. Merton, Priscilla Machado, Adam P. Dicker, Levon N. Nazarian |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-03-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2013.00073 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of Immunity by Antiangiogenic Molecules in Cancer
by: Magali Terme, et al.
Published: (2012-01-01) -
Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
by: Mitsuko Furuya, et al.
Published: (2011-01-01) -
Research on the Complexity Mechanism of Decoy Strategies Based on Multiagent Simulation
by: Zhen Li, et al.
Published: (2020-01-01) -
Using an inferior decoy alternative to nudge COVID-19 vaccination
by: Aikaterini Grimani, et al.
Published: (2025-01-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)